GRN
Basic information
Region (hg38): 17:44345246-44353106
Links
Phenotypes
GenCC
Source:
- neuronal ceroid lipofuscinosis 11 (Moderate), mode of inheritance: AR
- GRN-related frontotemporal lobar degeneration with Tdp43 inclusions (Strong), mode of inheritance: AD
- neuronal ceroid lipofuscinosis 11 (Moderate), mode of inheritance: AR
- neuronal ceroid lipofuscinosis 11 (Supportive), mode of inheritance: AR
- neuronal ceroid lipofuscinosis 11 (Strong), mode of inheritance: AR
- neuronal ceroid lipofuscinosis (Definitive), mode of inheritance: AR
- frontotemporal dementia and/or amyotrophic lateral sclerosis (Definitive), mode of inheritance: AD
- neuronal ceroid lipofuscinosis 11 (Strong), mode of inheritance: AR
- GRN-related frontotemporal lobar degeneration with Tdp43 inclusions (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Frontotemporal lobar degeneration with TDP43 inclusions, GRN-related; Neuronal ceroid lipofuscinosis 11 | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Neurologic; Ophthalmologic | 6497355; 9633693; 16862116; 16862115; 16983677; 16401619; 16983685; 16495329; 17436289; 17210807; 18392865; 18543312; 18183624; 18413474; 18703462; 18723524; 19884572; 20142524; 20142525; 22338605; 22366770; 22491866; 22608501; 22647257; 22815225; 22890101; 22906081; 22986778 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (38 variants)
- GRN-related frontotemporal lobar degeneration with Tdp43 inclusions;Neuronal ceroid lipofuscinosis 11 (26 variants)
- GRN-related frontotemporal lobar degeneration with Tdp43 inclusions (26 variants)
- Neuronal ceroid lipofuscinosis 11;GRN-related frontotemporal lobar degeneration with Tdp43 inclusions (24 variants)
- Frontotemporal dementia (10 variants)
- GRN-related disorder (3 variants)
- Primary progressive aphasia (3 variants)
- Neuronal ceroid lipofuscinosis 11 (2 variants)
- Inborn genetic diseases (2 variants)
- Amyotrophic lateral sclerosis type 10 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GRN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 123 | 130 | ||||
missense | 240 | 249 | ||||
nonsense | 22 | 28 | ||||
start loss | 2 | |||||
frameshift | 44 | 52 | ||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 11 | 12 | 24 | |||
splice region | 2 | 3 | 17 | 19 | 3 | 44 |
non coding | 48 | 64 | ||||
Total | 80 | 21 | 266 | 178 | 10 |
Highest pathogenic variant AF is 0.00000659
Variants in GRN
This is a list of pathogenic ClinVar variants found in the GRN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-44345270-G-T | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions • not specified • GRN-related frontotemporal lobar degeneration with Tdp43 inclusions;Neuronal ceroid lipofuscinosis 11 | Benign/Likely benign (May 01, 2024) | ||
17-44345286-T-G | not specified | Benign (May 25, 2017) | ||
17-44345297-C-G | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions • not specified | Likely benign (Nov 24, 2020) | ||
17-44345304-T-C | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions | Benign (Jan 13, 2018) | ||
17-44345320-C-T | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions | Uncertain significance (Apr 27, 2017) | ||
17-44345328-G-C | Likely benign (Aug 16, 2017) | |||
17-44345337-A-C | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions | Uncertain significance (Apr 27, 2017) | ||
17-44345337-A-G | Likely pathogenic (Mar 01, 2018) | |||
17-44345337-A-T | not provided (-) | |||
17-44345339-G-A | Neuronal ceroid lipofuscinosis 11;GRN-related frontotemporal lobar degeneration with Tdp43 inclusions | Uncertain significance (Apr 12, 2022) | ||
17-44345339-G-C | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions | Pathogenic (Oct 01, 2007) | ||
17-44345347-C-A | GRN-related disorder | Likely benign (Apr 15, 2019) | ||
17-44345380-G-T | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions;Neuronal ceroid lipofuscinosis 11 | Benign (Jan 31, 2021) | ||
17-44345383-C-CG | Benign (May 23, 2021) | |||
17-44345570-G-A | Likely benign (Oct 11, 2021) | |||
17-44348838-C-G | Benign (Aug 31, 2018) | |||
17-44349083-A-G | Likely benign (Feb 26, 2020) | |||
17-44349165-A-G | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions;Neuronal ceroid lipofuscinosis 11 | Pathogenic (Oct 27, 2021) | ||
17-44349166-T-C | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions • Neuronal ceroid lipofuscinosis 11;GRN-related frontotemporal lobar degeneration with Tdp43 inclusions | Pathogenic (Feb 22, 2023) | ||
17-44349167-G-A | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions | Pathogenic (Aug 24, 2006) | ||
17-44349169-G-A | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions;Neuronal ceroid lipofuscinosis 11 | Pathogenic (Nov 01, 2023) | ||
17-44349170-G-A | Likely pathogenic (Dec 01, 2016) | |||
17-44349171-A-G | Neuronal ceroid lipofuscinosis 11 | Uncertain significance (Jan 01, 2016) | ||
17-44349172-C-G | Neuronal ceroid lipofuscinosis 11;GRN-related frontotemporal lobar degeneration with Tdp43 inclusions | Uncertain significance (Jul 24, 2019) | ||
17-44349172-C-T | Inborn genetic diseases • Neuronal ceroid lipofuscinosis 11;GRN-related frontotemporal lobar degeneration with Tdp43 inclusions | Uncertain significance (Mar 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GRN | protein_coding | protein_coding | ENST00000053867 | 12 | 7857 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0697 | 0.930 | 125720 | 0 | 28 | 125748 | 0.000111 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.275 | 341 | 356 | 0.959 | 0.0000234 | 3881 |
Missense in Polyphen | 125 | 126.08 | 0.99141 | 1498 | ||
Synonymous | -1.25 | 165 | 146 | 1.13 | 0.0000108 | 1135 |
Loss of Function | 3.71 | 8 | 29.9 | 0.268 | 0.00000157 | 325 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000233 | 0.000231 |
European (Non-Finnish) | 0.000150 | 0.000132 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000163 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Granulins have possible cytokine-like activity. They may play a role in inflammation, wound repair, and tissue remodeling.;
- Disease
- DISEASE: Ubiquitin-positive frontotemporal dementia (UP-FTD) [MIM:607485]: Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years. It is an autosomal dominant neurodegenerative disease. {ECO:0000269|PubMed:16862116, ECO:0000269|PubMed:16983685, ECO:0000269|PubMed:18183624}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ceroid lipofuscinosis, neuronal, 11 (CLN11) [MIM:614706]: A form of neuronal ceroid lipofuscinosis characterized by rapidly progressive visual loss due to retinal dystrophy, seizures, cerebellar ataxia, and cerebellar atrophy. Cognitive decline may also occur. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material. {ECO:0000269|PubMed:22608501}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Integrated Breast Cancer Pathway;Neutrophil degranulation;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.430
Intolerance Scores
- loftool
- 0.597
- rvis_EVS
- -0.46
- rvis_percentile_EVS
- 23.66
Haploinsufficiency Scores
- pHI
- 0.118
- hipred
- N
- hipred_score
- 0.474
- ghis
- 0.487
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.802
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Grn
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; immune system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; pigmentation phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- grna
- Affected structure
- CaP motoneuron
- Phenotype tag
- abnormal
- Phenotype quality
- decreased length
Gene ontology
- Biological process
- signal transduction;regulation of signaling receptor activity;neutrophil degranulation
- Cellular component
- extracellular region;lysosome;endosome;endoplasmic reticulum;azurophil granule lumen;extracellular exosome
- Molecular function
- RNA binding;cytokine activity;protein binding;growth factor activity